Ankyrin-G Participates in I_Na Remodeling in Myocytes from the Border Zones of Infarcted Canine Heart

• Wen Dun ,

  * E-mail: pab4@columbia.edu

  Affiliation Department of Pharmacology, Center for Molecular Therapeutics, Columbia University, New York, New York, United States of America

  ⨯
• John S. Lowe,

  Affiliation The Ohio State University Wexner Medical Center, The Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Patrick Wright,

  Affiliation The Ohio State University Wexner Medical Center, The Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Thomas J. Hund,

  Affiliations The Ohio State University Wexner Medical Center, The Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America, Department of Biomedical Engineering,the Ohio State University College of Engineering, Columbus, Ohio, United States of America

  ⨯
• Peter J. Mohler,

  Affiliations The Ohio State University Wexner Medical Center, The Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America, Department of Internal Medicine, the Ohio State University, Columbus, Ohio, United States of America, Department of Biomedical Engineering, The Ohio State University College of Engineering, Columbus, Ohio, United States of America

  ⨯
• Penelope A. Boyden

  Affiliation Department of Pharmacology, Center for Molecular Therapeutics, Columbia University, New York, New York, United States of America

  ⨯